
|Articles|August 7, 2007
Quebec City in 1994, Montreal in 2001, and Toronto in 2007!
Quebec City in 1994, Montreal in 2001 and Toronto in 2007!
Advertisement
TORONTO, CANADA, July 26, 2007-Over the past fourteen years Anapharm has established itself as a world class provider of clinical and bioanalytical services to international sponsors and offers strategically located operations in five Canadian cities. Most recently, we opened a 160-bed clinical facility in Toronto, Canada.
Toronto site features:
- Modern, efficient facilities;
- Over 40,000 sq ft, on the 6th floor with ample natural light and park views;
- Clinical site comprised of 4 spacious clinical units with a total capacity of 160 beds;
- Units can be combined in order to conduct larger studies;
- The clinic offers full clinical services and on-site Quality Assurance support. Project Management services continue to be offered at the same level of excellence as at our Quebec and Montreal sites. One of our bioanalytical sites is located nearby in Richmond Hill.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA and EMA Align on Ten Principles to Guide Artificial Intelligence Use in Drug Development
2
New Phase II Data Suggest Maternal Nipocalimab Does Not Disrupt Infant Immune Development in Severe HDFN
3
Slower FDA Guidance Pushes Sponsors Toward Legacy Approaches
4
ACT Brief: FDA Capacity Strains Timelines, Sponsors Rethink Site Support, and Regulators Align on AI
5




